1. Myasthenia Gravis in Pregnancy Treated With Daily Massive Vitamin D Dose
- Author
-
Amaral Vm, Martins Mc, de Souza Va, Juliana Barroso Zimmermmann, Silva Lff, Panconi Cr, Silva Alm, Caplum Mc, Luz Ms, and de Souza Hd
- Subjects
Autoimmune disease ,medicine.medical_specialty ,Pregnancy ,biology ,Exacerbation ,business.industry ,General Medicine ,medicine.disease ,Myasthenia gravis ,Neuromuscular junction ,Proinflammatory cytokine ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Endocrinology ,030202 anesthesiology ,Internal medicine ,biology.protein ,medicine ,Vitamin D and neurology ,Antibody ,business ,030217 neurology & neurosurgery - Abstract
Myasthenia gravis (MG) is an autoimmune disease affecting the motor endplate of striated muscle. It is caused by antibodies that act in the cholinergic receptors at the post-synaptic portion of the neuromuscular junction, which results in asthenia and fatigue in some muscle groups. In pregnancy, it’s unpredictable, because pregnant women can present MG exacerbation, remission, stability, or even a myasthenic crisis during pregnancy. Complications are more frequent in the first trimester of pregnancy and the first 30 days of puerperium. Vitamin D and its metabolites are potent immunomodulators since their immuno-regulatory effect directly inhibits effector T cells and induces regulatory T cells (Treg) to decrease the production of inflammatory cytokines. The authors present a case report of a patient with MG who was treated throughout pregnancy with massive doses of vitamin D, obtaining good results.
- Published
- 2020